@dansfera: Ouch. The heat is on! 🔥 Former FDA Commissioner Scott Gottlieb went *off* on CROs regarding Risk-Based Monitoring (RBM). Imagine proposing RBM in 7 out of 10 contracts, only to watch sponsors slam the door on it 70% of the time! Are CROs too timid, or are sponsors stuck in the past? This captures the raw tension between industry push for efficiency and client resistance in clinical research. The regulatory world is watching this showdown closely. #ClinicalTrials #FDA #RBM #PharmaTech #CROs